Rejuvenate Biomed

Developer of drugs for treating sarcopenia

placeDiepenbeek, Flanders, Belgium calendar_todayFounded 2017 groups6 employees language rejuvenatebiomed.com

Registered entities

Social engagement

Social engagement: 3.8K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

3 investors on record; lead investors include Vesalius Biocapital III, Rejuveron Life Sciences.

Investor typeCountShare
Venture capital133%
Accelerator & incubator133%
Other / undisclosed133%

Recent activity

2 Jul 2026
Event
BIO 2026
15 Jun 2026
Event
BIO2026
5 Jun 2026
Event
KFG2026
Coming soon